Immunogenicity of COVID ‐19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy

Immunogenicity of COVID ‐19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy

Summary: Immune responses to primary COVID‐19 vaccination were investigated in 58 patients with follicular lymphoma (FL) as part of the PETReA trial of frontline therapy (EudraCT 2016–004010‐10). COVID‐19 vaccines (BNT162b2 or ChAdOx1) were administered before, during or after cytoreductive treatmen...

Полное описание

Библиографические подробности
Главные авторы:	Lim, YJ, Ward, V, Brown, A, Phillips, E, Kronsteiner, B, Malone, T, Jennings, D, Healy, S, Longet, S, James, T, Thomson, P, Farrell, L, Oates, M, Jackson, R, Morrison, A, Burns, M, Carroll, M, Klenerman, P, Turtle, L, Naisbitt, D, Rhodes, M, Robinson, K, Gatto, S, Young, M, Eyre, TA, Eyre, DW, Dunachie, S, Barnes, E
Формат:	Journal article
Язык:	English
Опубликовано:	Wiley 2024

Схожие документы

P1095: COVID-19 VACCINE RESPONSES IN FOLLICULAR LYMPHOMA: DETERMINANTS OF HUMORAL AND CELLULAR IMMUNITY IN THE PETREA TRIAL OF FRONTLINE CHEMOIMMUNOTHERAPY
по: Yeong Jer Lim, и др.
Опубликовано: (2023-08-01)

Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma
по: Reid W. Merryman, и др.
Опубликовано: (2023-02-01)

Follicular Lymphoma in Chile in the Adult Public Cancer Program: The Impact of Chemoimmunotherapy
по: María Elena Cabrera, и др.
Опубликовано: (2024-09-01)

Venous thromboembolism in primary central nervous system lymphoma during frontline chemoimmunotherapy
по: Hiu Lam Agnes Yuen, и др.
Опубликовано: (2020-08-01)

Symptomatic Follicular Lymphoma: Complete Remission After Chemoimmunotherapy with Bendamustine–Rituximab
по: Wulyo Rajabto, и др.
Опубликовано: (2024-04-01)

Two Follicular Dendritic Cell Sarcoma (FDCS) patients treated with Chemoimmunotherapy
по: Berksoy Sahin, и др.
Опубликовано: (2024-05-01)

Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era
по: Cristina Correia, и др.
Опубликовано: (2023-05-01)

Predictors of benefits from frontline chemoimmunotherapy in stage IV non-small-cell lung cancer: a meta-analysis
по: Hazem E. El-Osta, и др.
Опубликовано: (2019-12-01)

Survival in elderly follicular lymphoma patients who receive frontline chemo-immunotherapy.
по: Griffiths, R, и др.
Опубликовано: (2010)

Skeletal muscle radio-density is an independent predictor of response and outcomes in follicular lymphoma treated with chemoimmunotherapy.
по: Michael P Chu, и др.
Опубликовано: (2015-01-01)

mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals
по: Stephanie Longet, и др.
Опубликовано: (2022-09-01)

A phase 2 study of frontline pembrolizumab in follicular lymphoma
по: Carrie Ho, и др.
Опубликовано: (2024-12-01)

Low CCL19 expression is associated with adverse clinical outcomes for follicular lymphoma patients treated with chemoimmunotherapy
по: Yu Zhou, и др.
Опубликовано: (2021-09-01)

Quantitative study of Clostridium difficile transmission using extensive epidemiological data and whole genome sequencing
по: Eyre, DW
Опубликовано: (2013)

EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment
по: C. Martínez-Laperche, и др.
Опубликовано: (2022-09-01)

Early progression beyond first‐line chemoimmunotherapy in follicular lymphoma: Insights from a Fondazione Italiana Linfoma (FIL) study
по: Alberto Bavieri, и др.
Опубликовано: (2024-12-01)

Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment
по: C. Martínez-Laperche, и др.
Опубликовано: (2022-11-01)

Nanoparticle-Mediated Synergistic Chemoimmunotherapy for Cancer Treatment
по: Lang X, и др.
Опубликовано: (2024-05-01)

THE CHEMOIMMUNOTHERAPY BASED ON DENDRITIC CELLS AND CISPLATIN IN EXPERIMENT
по: Gorbach O. I., и др.
Опубликовано: (2014-08-01)

Age- and sex-specific differences in immune responses to BNT162b2 COVID-19 and live-attenuated influenza vaccines in UK adolescents
по: Cecilia Jay, и др.
Опубликовано: (2023-10-01)

Letter: Chemoimmunotherapy of adult acute leukaemia.
по: Peto, R, и др.
Опубликовано: (1975)

Application of Neoadjuvant Chemoimmunotherapy in Resectable NSCLC
по: Huaiyong WANG, и др.
Опубликовано: (2023-11-01)

MAPK signaling regulates the efficacy of chemoimmunotherapy
по: François Ghiringhelli
Опубликовано: (2022-12-01)

P1163: OUTCOMES OF HIGH-RISK LARGE B-CELL LYMPHOMA TREATED WITH STANDARD OF CARE CHEMOIMMUNOTHERAPY: A NON-RANDOMIZED COMPARISON TO FRONTLINE CAR-T CELL THERAPY
по: O. Albanyan, и др.
Опубликовано: (2022-06-01)

Rituximab maintenance significantly reduces early follicular lymphoma progressions in patients treated with frontline R‐CHOP
по: Vít Procházka, и др.
Опубликовано: (2020-07-01)

Teaching your children responsibility /
по: 424418 Eyre, Linda, и др.
Опубликовано: (1994)

A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy.
по: Robertson-Tessi, M, и др.
Опубликовано: (2015)

Use of lateral flow devices allows rapid triage of patients with SARS-CoV-2 on admission to hospital
по: Young, BC, и др.
Опубликовано: (2021)

Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy
по: Tianqi Wang, и др.
Опубликовано: (2021-04-01)

Targeted delivery of liposomal chemoimmunotherapy for cancer treatment
по: Yusheng Liu, и др.
Опубликовано: (2022-10-01)

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL
по: Adam S. Kittai, и др.
Опубликовано: (2025-02-01)

Hash-based core genome multilocus sequencing typing for Clostridium difficile
по: Eyre, DW, и др.
Опубликовано: (2019)

182 Peripheral immunological features as predictors of breast cancer chemoimmunotherapy response
по: Justin M Balko, и др.
Опубликовано: (2023-11-01)

Antibiotic Use and Survival in Patients With Late-Stage NSCLC Treated With Chemoimmunotherapy
по: Emanuela Taioli, MD, PhD, и др.
Опубликовано: (2024-12-01)

Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy
по: Yonghyun Lee, и др.
Опубликовано: (2023-08-01)

Fabrication of An Immunostimulatory Supramolecular Nanomedicine for Potent Cancer Chemoimmunotherapy
по: Xinyang Yu, и др.
Опубликовано: (2023-11-01)

Nanoparticles for Chemoimmunotherapy Against Triple-Negative Breast Cancer
по: Liu S, и др.
Опубликовано: (2022-11-01)

On the frontlines
по: Daniel Vila, и др.
Опубликовано: (2022-08-01)

Impact of shipping temperature on cell viability and T cell responses to bacterial antigens [version 1; peer review: 2 approved]
по: Susanna J. Dunachie, и др.
Опубликовано: (2023-04-01)

On the dynamics of tidal streams in the Milky Way galaxy
по: Eyre, A, и др.
Опубликовано: (2010)